NEWSROOM

Johannesburg

REPUBLIC OF SOUTH AFRICA MEDICAL MARIJUANA DISPENSARIES (RSAMMD) ANNOUNCES SUCCESSFUL TESTING RESULTS OF PROPRIETARY CANNABIS PLANT EXTRACTION TECHNOLOGY WITH JV PARTNER PROTEX PHARMA (TXTM)

Live Cannabis Plant Extraction into Highly Bioavailable, Non-psychoactive Cannabis Medicines Now Possible Johannesburg, South Africa–May 7th, 2020 – Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce the successful testing of its proprietary live cannabis plant extraction technology in conjunction with its joint venture partner, US-based Protext Pharma, Inc. (OTC PINK: TXTM). The testing took place over several days during the last couple months...

read more

REPUBLIC OF SOUTH AFRICA MEDICAL MARIJUANA DISPENSARIES (RSAMMD) SIGNS LETTER OF INTENT WITH USA-BASED PROTEXT PHARMA (TXTM) FOR COMMERCIALIZTION OF NEXT GENERATION LIVE CANNABIS AND HEMP EXTRACTION TECHNOLOGY

Johannesburg, South Africa, April 30th, 2020 – Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce it has executed a letter of intent with USA-based Protext Pharma, Inc (OTC PINK: TXTM)., a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated from highly-bioavailable plant extracts. Under the terms of the agreement, the companies will form a joint venture partnership to (i) test Protext’s proprietary...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »